Retatrutide: The Triple Agonist Redefining Metabolic Research

Retatrutide engages GLP-1R, GIPR and GCGR. Phase 2 and TRIUMPH Phase 3 publications have described weight and metabolic endpoints in clinical programmes. Materials supplied here remain laboratory reagents for qualified researchers.